What’s more, we observed similar changes on T cell infiltration in tumors with genomic gain in PIK3CA/PIK3CB as that in tumors with PTEN loss, which support the hypothesis that PI3K activation and PTEN loss yield similar impact on tumor immune microenvironment. The gene discussed is PIK3CA; the disease is neoplasm.